These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3176107)

  • 61. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
    Tod MM; Padoin C; Petitjean O
    Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bayesian forecasting of aminoglycoside dosing requirements in obese patients: influence of subpopulation versus general population pharmacokinetic parameters as the internal estimates.
    McClellan SD; Farringer JA
    Ther Drug Monit; 1989; 11(4):431-6. PubMed ID: 2741192
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Evaluation of a noninstrumented disposable method for quantifying serum theophylline concentrations.
    Asmus MJ; Milavetz G; Teresi ME; Weinberger MM
    Pharmacotherapy; 1998; 18(1):30-4. PubMed ID: 9469678
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Serum concentrations of theophylline in children treated with two daily doses of a sustained-release theophylline preparation.
    Sommer B; Pedersen SE; Nathan E
    Allergy; 1981 Oct; 36(7):507-11. PubMed ID: 7337199
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [24-hour lung function in asthmatic patients: chrono-optimal theophylline therapy as once-daily Euphylong administration vs conventional twice-daily administration].
    D'Alonzo GE; Smolensky MH; Feldman S; Gianotti LA; Emerson MB; Staudinger HW; Sauter R; Steinijans VW
    Pneumologie; 1991 Nov; 45 Suppl 4():834-41. PubMed ID: 1812476
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative pharmacokinetics of morning and evening doses of once-a-day theophylline capsules.
    Harrison LI; Kehe CR; Ekholm BP; Chang SF; Lavoie KA; Kisicki JC
    J Pharm Sci; 1994 Aug; 83(8):1171-4. PubMed ID: 7983603
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A comparison of graphical nomogram methods with a computerized Bayesian analysis method in the interpretation of serum phenytoin concentrations.
    Chrystyn H; Morgan DH
    J Clin Hosp Pharm; 1986 Dec; 11(6):443-8. PubMed ID: 3818966
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Individualization of oral theophylline dosage in elderly patients.
    Talseth T; Kornstad S; Boye NP; Bredesen JE
    Acta Med Scand; 1981; 210(6):489-92. PubMed ID: 7331897
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Adaptation of the oral dosage of theophylline to the asthmatic child. Value of a kinetic test by the intravenous route].
    Albertini M; Lapalus P; Maurin S; Boutte P; Mariani R
    Arch Fr Pediatr; 1982 Nov; 39(9):671-5. PubMed ID: 7165461
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A hand-held calculator program for individualized dosage adjustment of intravenous theophylline in acute asthma.
    Madsen BW; Tarala RA; Paterson JW
    Eur J Clin Pharmacol; 1980 May; 17(5):393-9. PubMed ID: 7418718
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dose-dependent kinetics for theophylline: observations among ambulatory asthmatic children.
    Sarrazin E; Hendeles L; Weinberger M; Muir K; Riegelman S
    J Pediatr; 1980 Nov; 97(5):825-8. PubMed ID: 7431179
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Theophylline disposition in Korean patients with congestive heart failure.
    Jeong CS; Hwang SC; Jones DW; Ryu HS; Sohn K; Sands CD
    Ann Pharmacother; 1994 Mar; 28(3):396-401. PubMed ID: 8193433
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Disposition and clinical pharmacokinetics of microcrystalline theophylline.
    Jonkman JH; Berg WC; Schoenmaker R; de Zeeuw RA; Greving JE; Orie NG
    Eur J Clin Pharmacol; 1980 May; 17(5):379-84. PubMed ID: 7418716
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparison of a Bayesian program with three microcomputer programs for predicting gentamicin concentrations.
    Godley PJ; Black JT; Frohna PA; Garrelts JC
    Ther Drug Monit; 1988; 10(3):287-91. PubMed ID: 3176104
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Temporal variations in trough serum theophylline concentrations at steady state.
    Lesko LJ; Brousseau D; Canada AT; Eastwood G
    J Pharm Sci; 1980 Mar; 69(3):358-9. PubMed ID: 7381723
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Apparent decrease in population clearance of theophylline: implications for dosage.
    Asmus MJ; Weinberger MM; Milavetz G; Marshik P; Teresi ME; Hendeles L
    Clin Pharmacol Ther; 1997 Nov; 62(5):483-9. PubMed ID: 9390104
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Individualizing theophylline dosage: evaluation of a single-point maintenance dose prediction method.
    Wilkens JH; Neuenkirchen H; Sybrecht GW; Oellerich M
    Eur J Clin Pharmacol; 1984; 26(4):491-8. PubMed ID: 6734708
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults.
    Tegenge MA; Mahmood I
    Ther Drug Monit; 2018 Oct; 40(5):635-641. PubMed ID: 30086085
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Theophylline levels and clinical response in asthmatic adults receiving long-term Uniphyl.
    Petty TL; Rollins DL
    Am J Med; 1985 Dec; 79(6A):73-6. PubMed ID: 2867679
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.